Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation

Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) today announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (NASDAQ: SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals.

The Court found in favor of the plaintiffs (on all but three counts deemed to have been waived). However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.

You May Also Be Interested In

• Entegris Executive Chair Loy to retire, Gentilcore named board chair
• The Lancet publishes Capricor's phase 3 DMD therapy trial results
• FDA closes inspection of Alvotech's Iceland facility with VAI rating